Sign inGet started

Louis Roger

Insider CIK 1659747 · AEGR See Remarks · NVLN See Remarks

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NVLN NOVELION THERAPEUTICS INC. F Tax w/h2019-05-092019-05-13155$1.22 $1891,162SEC↗
NVLN NOVELION THERAPEUTICS INC. F Tax w/h2018-05-092018-05-11161$4.26 $6861,317SEC↗
NVLN NOVELION THERAPEUTICS INC. A Award deriv2018-02-122018-02-1425,000— $025,000SEC↗
NVLN NOVELION THERAPEUTICS INC. M Exercise deriv2017-05-092017-05-11547— $01,093SEC↗
NVLN NOVELION THERAPEUTICS INC. M Exercise2017-05-092017-05-11547— $0547SEC↗
NVLN NOVELION THERAPEUTICS INC. F Tax w/h2017-05-092017-05-11162$9.42 $1.5K385SEC↗
NVLN NOVELION THERAPEUTICS INC. A Award deriv2016-12-222016-12-2741,740— $041,740SEC↗
AEGR Aegerion Pharmaceuticals, D To issuer deriv2016-11-292016-11-308,000— $00SEC↗
AEGR Aegerion Pharmaceuticals, D To issuer deriv2016-11-292016-11-3085,000— $00SEC↗
AEGR Aegerion Pharmaceuticals, D To issuer deriv2016-11-292016-11-3017,000— $00SEC↗
NVLN QLT INC/BC A Award deriv2016-11-292016-12-018,204— $08,204SEC↗
AEGR Aegerion Pharmaceuticals, A Award deriv2016-05-092016-05-118,000— $08,000SEC↗
AEGR Aegerion Pharmaceuticals, A Award deriv2016-05-092016-05-1117,000— $017,000SEC↗
AEGR Aegerion Pharmaceuticals, A Award deriv2015-12-012015-12-0285,000— $085,000SEC↗